PRINCETON, N.J. Feb. 4, 2011 Craig Kessler Georgetown University
With the potential to help clinicians quickly and more accurately diagnose bleeding disorders, the app provides for the first time, in one place, information about bleeding disorders and their effects on coagulation laboratory tests.
The basis for the app came from U.S. market research results, which identified a gap in many specialists’ recognition of abnormal blood clotting activity in a bleeding patient; often resulting in a focus on the location of the bleed rather than the cause. These findings were presented at the 2010 American Society of Hematology (ASH) Annual Meeting.
About Novo Nordisk
Denmark Copenhagen novonordisk-us.com
iPhone and iTunes are registered trademarks of Apple Inc.
SOURCE Novo Nordisk